Graded by the fifth independent annual benchmark evaluation of the Spanish healthcare sector, Monitor de Reputación Sanitaria (MRS), the Medical Oncology Department of the Vall d’Hebron University Hospital (HUVH), championed by Josep Tabernero, Director of VHIO and President of the European Society for Medical Oncology (ESMO), ranks first among clinical services in medical oncology with the very best reputation at national level for a fifth year running.

Additionally, our Hospital, located within the Vall d’Hebron Barcelona Hospital Campus, earns 5th place in the ranking of public hospitals throughout Spain and also secures top 5 slot listings for specialties including: allergology, cardiology, general & digestive system surgery, gynecology and obstetrics, hospital pharmacy, internal medicine, nephrology, neurology, oral & maxillofacial surgery, orthopedic surgery & traumatology, pediatrics, pneumology, psychiatry, and radiodiagnostics.

In recognition of these achievements, we at the Vall d’Hebron Institute of Oncology (VHIO), would like to congratulate both the HUVH and Josep Tabernero, as well as recognize the outstanding dedication and commitment of his exceptional team of oncology professionals — the driving force behind Spain’s leading Medical Oncology Service.

Not only do we thoroughly applaud the tremendous efforts of the entire Department, we also take the opportunity to recognize those medical oncologists who, in addition to their duties as leading physicians, also carry out clinical research of excellence at VHIO.

Speaking of research and also announced today, both Josep Tabernero, VHIO’s Director, and Principal Investigator of our Thoracic Tumors & Head and Neck Cancer Group, Enriqueta Felip, have been named in the Clarivate Analytics annual Global Highly Cited Researchers (HCRs) list for 2018.

To discover more please see today’s earlier VHIO news: VHIO’s Josep Tabernero and Enriqueta Felip both named in Global Highly Cited Researchers list 2018.

###